Table 2:
Autoantbodies detected in combined sample
| Autoantibodies, n (%) | |
|---|---|
| Cell-surface (total) | 59 (62) |
| AMPAR | 2 (2) |
| CASPR2 | 1 (1) |
| GABAb | 3 (3) |
| GlyR | 1 (1) |
| LGI1 | 20 (21) |
| NMDAR | 31 (33) |
| VGCC | 1 (1) |
| Intracellular (total) | 15 (16) |
| GAD | 4 (4) |
| GFAP | 1 (1) |
| Hu | 2 (2) |
| Ma2 | 4 (4) |
| SOX1 | 1 (1) |
| Yo | 3 (3) |
| Others (total) | 2 (2) |
| ADEM | 1 (1) |
| SREAT | 1 (1) |
| Antibody-negative AE | 19 (20) |
| Total | 95 (100) |
AE: autoimmune encephalitis; AMPA: alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor; ADEM: acute disseminated encephalomyelitis; CASPR2: contacting-associated protein-like 2; GABAb: gamma aminobutyric acid; GFAP: glial fibrillary acidic protein; GlyR: glycine Receptor; LGI1: leucine-rich glioma inactivated 1; NMDAR: N-methyl-D-aspartate receptor; SREAT: steroid-responsive encephalopathy associated with autoimmune thyroiditis; VGCC: voltage-gated calcium channel.